Skip to main content

Automated evaluation and correction of generation bias in immune receptor repertoires

Project description

Immune repertoire analysis software

Advances in sequencing technology give scientists the ability to determine the immune repertoire of an individual and identify the pathogens they have encountered in life. This immune sequencing, however, generates Big Data that is hard or laborious to analyse. The aim of the EU-funded PGEN project is to develop software for the analysis of immune sequencing data. The PGEN solution will be user friendly and will not require bioinformatics expertise. This means it can be implemented by clinicians to identify potential immune system dysfunctions or by scientific personnel in pharmaceutical companies for vaccine design.

Host institution

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Net EU contribution
€ 142 406,00
Address
Rue Michel Ange 3
75794 Paris
France

See on map

Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Other funding
€ 0,00

Beneficiaries (2)

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
France
Net EU contribution
€ 142 406,00
Address
Rue Michel Ange 3
75794 Paris

See on map

Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Other funding
€ 0,00
Third-party

Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.

CNRS INNOVATION
France
Net EU contribution
€ 7 500,00
Address
79 Avenue Edouard Vaillant Le Quintet Bat D
92100 Boulogne-billancourt

See on map

Region
Ile-de-France Ile-de-France Hauts-de-Seine
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00